HIV Citation List: October 14, 2011 - October 27, 2011
Pubmed citations
1. Structure-Based Identification and Neutralization Mechanism of Tyrosine Sulfate Mimetics That Inhibit HIV-1 Entry. Acharya, P., C. Dogo-Isonagie, J.M. Lalonde, S.N. Lam, G.J. Leslie, M.K. Louder, L.L. Frye, A.K. Debnath, J.R. Greenwood, T.S. Luongo, L. Martin, K.S. Watts, J.A. Hoxie, J.R. Mascola, C.A. Bewley, and P.D. Kwong, ACS Chemical Biology, 2011. 6(10): p. 1069-1077; PMID[21793507].
[Pubmed]. HIV_1014-102711.
2. Discovery of Novel Promising Targets for Anti-AIDS Drug Developments by Computer Modeling: Application to the HIV-1 gp120 V3 Loop. Andrianov, A.M., I.V. Anishchenko, and A.V. Tuzikov, Journal of Chemical Information and Modeling 2011. 51(10): p. 2760-2767; PMID[21888425].
[Pubmed]. HIV_1014-102711.
3. Difluoromethylbenzoxazole Pyrimidine Thioether Derivatives: A Novel Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Boyer, J., E. Arnoult, M. Medebielle, J. Guillemont, J. Unge, and D. Jochmans, Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[22017513].
[Pubmed]. HIV_1014-102711.
4. The Antiretroviral Protease Inhibitors Indinavir and Nelfinavir Stimulate Mrp1-mediated GSH Export from Cultured Brain Astrocytes. Brandmann, M., K. Tulpule, M.M. Schmidt, and R. Dringen, Journal of Neurochemistry, 2011. [Epub ahead of print]; PMID[22017299].
[Pubmed]. HIV_1014-102711.
5. A Single Step Assay for Rapid Evaluation of Inhibitors Targeting HIV Type 1 Tat-Mediated Long Terminal Repeat Transactivation. Chande, A.G., M. Baba, and R. Mukhopadhyaya, AIDS Research and Human Retroviruses, 2011. [Epub ahead of print]; PMID[21878060].
[Pubmed]. HIV_1014-102711.
6. Evaluation of the Synthesis of Sialic Acid-PAMAM Glycodendrimers Without the Use of Sugar Protecting Groups, and the Anti-HIV-1 Properties of These Compounds. Clayton, R., J. Hardman, C.C. Labranche, and K.D. McReynolds, Bioconjugate Chemistry, 2011. 22(10): p. 2186-2197; PMID[21859137].
[Pubmed]. HIV_1014-102711.
7. Stimulation of hRAD51 Nucleofilament Restricts HIV-1 Integration in Vitro and in Infected Cells. Cosnefroy, O., A. Tocco, P. Lesbats, S. Thierry, C. Calmels, T. Wiktorowicz, S. Reigadas, Y. Kwon, A. De Cian, S. Desfarges, P. Bonot, J. San Filippo, S. Litvak, E. Le Cam, A. Rethwilm, H. Fleury, P.P. Connell, P. Sung, O. Delelis, M.L. Andreola, and V. Parissi, Journal of Virology, 2011. [Epub ahead of print]; PMID[22013044].
[Pubmed]. HIV_1014-102711.
8. Classification of anti-HIV Compounds Using Counterpropagation Artificial Neural Networks and Decision Trees. Jalali-Heravi, M., A. Mani-Varnosfaderani, P.E. Jahromi, M.M. Mahmoodi, and D. Taherinia, SAR and QSAR in Environmental Research, 2011. [Epub ahead of print]; PMID[21999803].
[Pubmed]. HIV_1014-102711.
9. Synthesis of Conformationally North-Locked Pyrimidine Nucleosides Built on an Oxa-bicyclo[3.1.0]hexane Scaffold. Ludek, O.R. and V.E. Marquez, The Journal of Organic Chemistry, 2011. [Epub ahead of print]; PMID[22026578].
[Pubmed]. HIV_1014-102711.
10. Ferrocenyl chalcone difluoridoborates inhibit HIV-1 integrase and display low activity towards cancer and endothelial cells. Monserrat, J.P., R.I. Al-Safi, K.N. Tiwari, L. Quentin, G.G. Chabot, A. Vessieres, G. Jaouen, N. Neamati, and E.A. Hillard, Bioorganic & Medicinal Chemistry Letters, 2011. 21(20): p. 6195-7; PMID[21889342].
[Pubmed]. HIV_1014-102711.
11. Development of Anti-HIV Activity Models of Lysine Sulfonamide Analogs: A QSAR Perspective. Muthukumaran, R., B. Sangeetha, R. Amutha, and P.P. Mathur, Current Computer Aided Drug Design, 2011. [Epub ahead of print]; PMID[21999609].
[Pubmed]. HIV_1014-102711.
12. Biophysical Investigations of GBV-C E1 Peptides as Potential Inhibitors of HIV-1 Fusion Peptide. Sanchez-Martin, M.J., P. Urban, M. Pujol, I. Haro, M.A. Alsina, and M.A. Busquets, ChemPhysChem, 2011. 12(15): p. 2816-2822; PMID[21905195].
[Pubmed]. HIV_1014-102711.
13. In Silico Design of Multi-target Inhibitors for C-C Chemokine Receptors Using Substructural Descriptors. Speck-Planche, A. and V.V. Kleandrova, Molecular Diversity, 2011. [Epub ahead of print]; PMID[22020812].
[Pubmed]. HIV_1014-102711.
14. Novel Diarylpyridinones, Diarylpyridazinones and Diarylphthalazinones as Potential HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs). Venkatraj, M., K.K. Arien, J. Heeres, B. Dirie, J. Joossens, S. Van Goethem, P. Van der Veken, J. Michiels, C.M. Vande Velde, G. Vanham, P.J. Lewi, and K. Augustyns, Bioorganic & Medicinal Chemistry, 2011. 19(20): p. 5924-5934; PMID[21930388].
[Pubmed]. HIV_1014-102711.
15. Cordysobin, a Novel Alkaline Serine Protease with HIV-1 Reverse Transcriptase Inhibitory Activity from the Medicinal Mushroom Cordyceps sobolifera. Wang, S.X., Y. Liu, G.Q. Zhang, S. Zhao, F. Xu, X.L. Geng, and H.X. Wang, Journal of Bioscience and Bioengineering 2011. [Epub ahead of print]; PMID[22014786].
[Pubmed]. HIV_1014-102711.
16. Molecules from Apoptotic Pathways Modulate HIV-1 Replication in Jurkat Cells. Wang, X., V. Ragupathy, J. Zhao, and I. Hewlett, Biochemical and Biophysical Research Communications, 2011. 414(1): p. 20-24; PMID[21945613].
[Pubmed]. HIV_1014-102711.
17. Single Chain Fv-based anti-HIV Proteins: Potential and Limitations. West, A.P., Jr., R.P. Galimidi, P.N. Gnanapragasam, and P.J. Bjorkman, Journal of Virology, 2011. [Epub ahead of print]; PMID[22013046].
[Pubmed]. HIV_1014-102711.
ISI Web of Knowledge citations
18. Polyanionic Inhibitors of HIV Adsorption. Baranova, E.O., N.S. Shastina, and V.I. Shvets, Russian Journal of Bioorganic Chemistry, 2011. 37(5): p. 527-542; ISI[000295533200002].
[WOS]. HIV_1014-102711.
19. Comprehensive Analysis of the Intracellular Metabolism of Antiretroviral Nucleosides and Nucleotides Using Liquid Chromatography-tandem Mass Spectrometry and Method Improvement by Using Ultra Performance Liquid Chromatography. Coulier, L., H. Gerritsen, J.J.A. van Kampen, M.L. Reedijk, T.M. Luider, A. Osterhaus, R.A. Gruters, and L. Brull, Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 2011. 879(26): p. 2772-2782; ISI[000295297800014].
[WOS]. HIV_1014-102711.
20. The Effects of RNase H Inhibitors and Nevirapine on the Susceptibility of HIV-1 to AZT and 3TC. Davis, C.A., M.A. Parniak, and S.H. Hughes, Virology, 2011. 419(2): p. 64-71; ISI[000295422500002].
[WOS]. HIV_1014-102711.
21. Strategies to Improve Efficacy and Safety of a Novel Class of Antiviral Hyper-activation-limiting Therapeutic Agents: The VS411 Model in HIV/AIDS. De Forni, F., M.R. Stevens, and F. Lori, British Journal of Pharmacology, 2011. 164(4): p. 1392-1392; ISI[000295218600018].
[WOS]. HIV_1014-102711.
22. The HIV Protease Inhibitor Nelfinavir has Proteasome-inhibiting Activity in Vivo Distinct from Bortezomib. Kraus, M., J. Bader, D. Hess, S. Haile, H. Overkleeft, and C. Driessen, Onkologie, 2011. 34: p. 159-159; ISI[000295160600416].
[WOS]. HIV_1014-102711.
23. Specificity of RSG-1.2 Peptide Binding to RRE-IIB RNA Element of HIV-1 over Rev Peptide is Mainly Enthalpic in Origin. Kumar, S., D. Bose, H. Suryawanshi, H. Sabharwal, K. Mapa, and S. Maiti, Plos One, 2011. 6(8); ISI[000295454200068].
[WOS]. HIV_1014-102711.
24. HIV-1 Protease Inhibitors with a Tertiary Alcohol Containing Transition-state Mimic and Various P2 and P1 ' Substituents. Ohrngren, P.W., XY Persson, M Ekegren, JK Wallberg, H Vrang, L Rosenquist, A Samuelsson, B Unge, T Larhed, M, Medchemcomm, 2011. 2(8): p. 701-709; ISI[000295068100003].
[WOS]. HIV_1014-102711.
25. Design, Synthesis, and Evaluation of Thiazolidinone Derivatives as Antimicrobial and Anti-viral Agents. Ravichandran, V., A. Jain, K.S. Kumar, H. Rajak, and R.K. Agrawal, Chemical Biology & Drug Design, 2011. 78(3): p. 464-470; ISI[000294990900014].
[WOS]. HIV_1014-102711.
26. Diastereoselective Synthesis of (Aryloxy)phosphoramidate Prodrugs. Roman, C.A., P. Wasserthal, J. Balzarini, and C. Meier, European Journal of Organic Chemistry, 2011(25): p. 4899-4909; ISI[000295211500022].
[WOS]. HIV_1014-102711.
27. An Evaluation of the RNase H Inhibitory Effects of Vietnamese Medicinal Plant Extracts and Natural Compounds. Tai, B.H., N.D. Nhut, N.X. Nhiem, T.H. Quang, T.T.N. Nguyen, T.T.L. Bui, T.T. Huong, J. Wilson, J.A. Beutler, N.K. Ban, N.M. Cuong, and Y.H. Kim, Pharmaceutical Biology, 2011. 49(10): p. 1046-1051; ISI[000295084400008].
[WOS]. HIV_1014-102711.
28. Evaluation of Cynanchum otophyllum glucan sulfate against Human Immunodeficiency Virus and Herpes Simplex Virus as a Microbicide Agent. Tao, J., J. Yang, C.Y. Chen, X.M. Cao, S.L. Zhao, and K.L. Ben, Indian Journal of Pharmacology, 2011. 43(5): p. 536-540; ISI[000295294700010].
[WOS]. HIV_1014-102711.
29. Product and Process Understanding of a Novel Pediatric anti-HIV Tenofovir Niosomes with a High-pressure Homogenizer. Zidan, A.S., Z. Rahman, and M.A. Khan, European Journal of Pharmaceutical Sciences, 2011. 44(1-2): p. 93-102; ISI[000295109400012].
[WOS]. HIV_1014-102711.
Meeting Abstract citations
30. BI 224436, a Non-Catalytic Site Integrase Inhibitor, is a Potent Inhibitor of the Replication of Treatment-naïve and Raltegravir-resistant Clinical Isolates of HIV-1. Fenwick, C., R. Bethell, M. Cordingley, P. Edwards, A-M. Quinson, P. Robinson, B. Simoneau. C. Yoakim, 51st ICAAC, 2011.
HIV_1014-102711.
31. Pharmacodynamics of BI 224436 for HIV-1 in an in Vitro Hollow Fiber Infection Model System. Brown, A.N., J. McSharry, R. Kulawy, C. Fenwick, R. Bethell, J. Duan, J. Kort, P. Robinson, B. Simoneau, C. Yoakim, G. Drusano, 51st ICAAC, 2011.
HIV_1014-102711.
32. Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic Site Integrase Inhibitor. Yoakim, C., M. Amad, M.D. Bailey, R. Bethell, M. Bos, P. Bonneau, M. Cordingley, R. Coulombe, J. Duan, P. Edwards, L. Fader, A-M Faucher, M. Garneau, A. Jakalian, S. Kawai, L. Lamorte, S. LaPlante, L. Luo, S. Mason, M-A Poupart, N. Rioux, B. Simoneau, Y. Tsantrizos, M. Witvrouw, C.F. Boehringer, 51st ICAAC, 2011.
HIV_1014-102711.